Innovative Ideas. Revolutionary Results.
Who We Are
EverGlade BIO is reinvigorating the development of therapeutics for cancer and the treatment of their side effects, one important product at a time. We are committed to advancing drugs that treat cancer and minimizing the impact of cancer on lives. EverGlade BIO’s commitment extends beyond cancer treatment – we are actively engaged in developing strategies to mitigate therapy-related side effects for better patient outcomes and ensuring a more comfortable and effective treatment experience.
EverGlade BIO was founded by Eric Jia-Sobota and is comprised of pharmaceutical and clinical research executives, quality and regulatory leaders, and governmental experts. Together, we are committed to advancing innovative cancer therapies with a strong emphasis on minimizing side effects, enhancing the overall well-being of patients.